Previous studies have demonstrated that the administration of testosterone in rats for the induction of BPH enhanced the proliferation of the prostatic tissue, which was supported by the upregulation of cell proliferative markers such as cyclin D1 and PCNA [36,37]. The gene discussed is PCNA; the disease is benign prostatic hyperplasia.